top of page

Medical Studies

Clinicopathologic Characteristics and Response to Treatment of Persistent Chemotherapy-Induced Alopecia in Breast Cancer Survivors

Permanent hair loss associated with taxane chemotherapy use in breast cancer: A retrospective survey at two tertiary UK cancer centres May 2021

 

Breast Cancer Research and Treatment, 2018: Persistent Major Alopecia Following Adjuvant Docetaxel for Breast Cancer: Incidence, Characteristics, and Prevention with Scalp Cooling

Supportive Care in Cancer, 2015: Measurement of Chemotherapy-Induced Alopecia—Time to Change

International Journal of Endocrinology & Metabolism, 2013:
Female Pattern Hair Loss

Journal of the American Academy of Dermatology, 2011:
Permanent Chemotherapy-Induced Alopecia: A Review

Journal of the American Academy of Dermatology, 2010:
Permanent chemotherapy-induced alopecia: Case Report and Review of the Literature

FDA Warning Letter, 2009

Breast Cancer Research and Treatment, 2018: Persistent Major Alopecia Following Adjuvant Docetaxel for Breast Cancer: Incidence, Characteristics, and Prevention with Scalp Cooling

Clinicopathologic Characteristics and Response to Treatment of Persistent Chemotherapy-Induced Alopecia in Breast Cancer Survivors - PubMed (nih.gov)

Hair Regrowth Trials and Studies

While there is no cure for pCIA there has recently been two trials involving low dose Minoxidil which has shown success for some. It is being used off-label but maybe we will see a change in the near future as more studies and long term usage information becomes available.  

If you have been involved in either of these trials or have a story to tell if you have used Minoxidil under medical supervision and would like to share your story, please get in touch with us.

https://ascopost.com/issues/december-10-2022/how-low-dose-oral-minoxidil-is-providing-hope-for-patients-with-later-stage-alopecia/

alopecia, breast cancer, docetaxel, hair loss,  paclitaxel,  taxane, Taxotere, chemotherapy Minoxidil 

 

bottom of page